Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209644) titled 'Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis' on Sept. 29.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Systemic Sclerosis
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2026
Target Sample Size: 70
To know more, visit https://clinicaltrials.gov/study/NCT07209644
Disclaimer: Curated by HT Syndication....